Last updated on September 2018

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Brief description of study

The study aim is to investigate the efficacy and safety of Osilodrostat in patients with Cushing's syndrome due to causes other than Cushing's disease in Japan.

Clinical Study Identifier: NCT02468193

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Fukushima-city, Japan